Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.

Comments

Hi! At Alonti Catering we have a new rewards program!! We offer 7.5% cash back on all catering purchases in Houston, Austin, DFW, San Antonio, Chicago, and LA!! We think this would great for Medical Reps! Check out our program at
Dear Sir/Madam,
We gone through your company profile, Based on your company research work and company credibility, Biosimilars 2019 cordially invites you to be as a speaker/delegate/exhibitor/sponsor at Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress during October 17- 19, 2019 at Rome, Italy.

For more info visit: https://frontiersmeetings.com/conferences/biosimilars/

Kindly let us know about your participation interest

Regards
Jon Peters | Program Director
Biosimilars Conferences
T: +44 2034554929
[email protected]

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering and developing breakthrough treatments for human disease.

Operating as usual

Timeline photos 02/28/2022

Lexicon Pharmaceuticals Reports Fourth Quarter & Full-Year 2021 Financial Results and Provides Clinical Update. To view the full press release, visit our website: https://zcu.io/MuRI

Timeline photos 02/28/2022

Lexicon Voluntarily Withdraws Sotagliflozin New Drug Application and Plans Prompt Resubmission Targeted Early Q2 2022. To view the full press release, visit our website: https://zcu.io/LUST

Timeline photos 02/27/2022

Lexicon Pharmaceuticals to Host Fourth Quarter 2021 Financial Results Conference Call & Webcast on February 28, 2022. For more information, please visit our website: https://zcu.io/M4z0

02/19/2022

That’s a wrap on ! We appreciated listening and joining in on important conversations surrounding heart failure this week.

02/17/2022

Did you know 6.2 million adults in the US have heart failure? Although this may sound as if the heart isn’t working, the diagnosis means the heart isn’t pumping as well as it should. Read more: https://hfsa.org/heart-success-function-not-failure-announced-theme-hfsa-heart-failure-awareness-week-2022

02/15/2022

The theme for this year’s Heart Failure Awareness Week is “Heart Success: Function Not Failure.” This theme is working to shine light on all that can be done to treat heart failure. View more: https://hfsa.org/heart-success-function-not-failure-announced-theme-hfsa-heart-failure-awareness-week-2022

02/13/2022

Today kicks off Heart Failure Awareness Week – a nationwide campaign focused on bringing awareness to the risk factors, signs, symptoms and treatment of heart failure. Learn more: https://zcu.io/mfEs

Timeline Photos 01/14/2022

We presented yesterday at . If you missed it, you can watch what we presented here: https://zcu.io/FYvV

Timeline Photos 01/13/2022

Lexicon Pharmaceuticals Outlines Major Potential Value for 2022 at 40th Annual J.P. Morgan Healthcare Conference. To read the full press release, visit our website: https://zcu.io/4NyE

Timeline Photos 01/05/2022

Lexicon Pharmaceuticals to Participate in the 40th Annual J.P. Morgan Healthcare Conference. To view the full press release, please visit our website: https://zcu.io/bg00

Timeline Photos 12/30/2021

Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults with Type 2 Diabetes. To read the full press release, visit our website: https://zcu.io/UJL4

Timeline Photos 12/20/2021

“Proud of SOLOIST and SCORED mention by the AHA as one of the Top Heart Disease and Stroke Research Advances of 2021. Recognition from the scientific community continues to build for the unique and important agent studied” – Craig Granowitz, M.D., Ph.D.
To view the AHA press release, visit their website: https://zcu.io/KD3f

Photos from Lexicon Pharmaceuticals, Inc.'s post 12/16/2021

The holiday season is here! Lexicon celebrated with a virtual holiday event, Nailed It – Painting Edition, where employees completed a 16x20 canvas together followed by a friendly competition of who painted best. Oh what fun it is to see the creative & competitive drive in our teams!

Timeline Photos 12/03/2021

Lexicon Pharmaceuticals’ chief medical officer, Craig Granowitz, will be participating in the 18th Global Cardiovascular Clinical Trialists Forum today. View information on the panel discussion and Q&A here: https://zcu.io/WD0O

Timeline Photos 11/22/2021

Now Available On Demand - Lexicon Pharmaceuticals presents at the Piper Sandler 33rd Annual Healthcare Conference. To view the webcast: https://zcu.io/zEwD

Timeline Photos 11/18/2021

Now Available On Demand - Lexicon Pharmaceuticals presents at the Jefferies London Healthcare Conference. To view the webcast: https://zcu.io/XWfH

Timeline Photos 11/16/2021

That’s a wrap for this year’s virtual . Thank you for another great year! View more on Lexicon’s involvement here: https://zcu.io/BcGH

Timeline Photos 11/15/2021

Lexicon Pharmaceuticals to Particpate in the Jefferies London Healthcare Conference & the Piper Sandler 33rd Annual Healthcare Conference. To read the full press release, visit our website: https://zcu.io/qE77

Timeline Photos 11/15/2021

Dr. Deepak L. Bhatt, MD, MPH presented a new analysis of the cardiovascular effects of SGLT1/2 inhibition across the full range of kidney function at . View more: https://zcu.io/55ZY

Timeline Photos 11/14/2021

Dr. Deepak L. Bhatt, MD, MPH presenting data now at . View more: https://zcu.io/dpEp

Timeline Photos 11/13/2021

kicks off today! Hear the latest health news including Dr. Deepak L. Bhatt, MD, MPH presentation tomorrow at 8:24 am ET. https://zcu.io/xOoo

11/11/2021

kicks off this Saturday! Don’t miss the latest news in the world of health. More from Lexicon and Dr. Deepak L. Bhatt, MD, MPH here: https://www.lexpharma.com/media-center/news/791-new-analysis-to-be-presented-at-the-american-heart-association-scientific-sessions-2021-evaluating-cardiovascular-benefits-across-baseline-kidney-function

Timeline Photos 11/09/2021

We’re looking forward to participating in . Learn more about our involvement here: https://zcu.io/RbFb

Timeline Photos 11/03/2021

Join us today at 4 pm CST, for the Third Quarter 2021 Financial Results Update webcast. Link to the webcast, can be found on our website: https://zcu.io/6reb

Timeline Photos 11/03/2021

Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results Update. For more information, please visit our website: https://zcu.io/3fKo

Timeline Photos 10/29/2021

Lexicon Pharmaceuticals’ Chief Medical Officer, Craig Granowitz, among distinguished panelists for the 17th International Conference on Emerging Technologies for a Smarter World (CEWIT2021). For more information on attending, visit their website: https://zcu.io/F6Vo

Timeline Photos 10/29/2021

Lexicon Pharmaceuticals to Host Third Quarter 2021 Financial Results Conference Call & Webcast on November 3, 2021. For more information, visit our website: https://zcu.io/Kp0F

Timeline Photos 10/04/2021

American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) jointly issue their consensus report on the management of type 1 diabetes in adults. Co-published in Diabetes Care and Diabetologia. Read the entire report here: https://zcu.io/l2em
https://zcu.io/USQB

Timeline Photos 10/01/2021

That’s a wrap for this year’s virtual EASD Annual Meeting 2021. Thank you for another great year!

Timeline Photos 09/28/2021

Hear the latest science on the potential benefits of SGLT inhibitors in type 1 diabetes during the short oral discussion event B (Tuesday, September 28 at 1:15 pm CEST/7:15 am ET) :

Session 606: “Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines”

09/27/2021

Looking forward to hearing the latest science on diabetes. Virtual EASD Annual Meeting 2021 kicks off this week starting today!

09/20/2021

Tomorrow at 10:45 a.m. ET, Lexicon Pharmaceuticals will present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit. Please visit our website for webcast information: https://www.lexpharma.com/events

09/15/2021

Lexicon Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit on September 21, 2021. To view the full press release, visit our website: https://www.lexpharma.com/media-center/news/787-lexicon-pharmaceuticals-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit

08/31/2021

That’s a wrap on 2021! View more on Lexicon’s involvement here: https://www.lexpharma.com/

08/30/2021

2021 guidelines establish SGLT inhibitors as part of the standard of care in acute and chronic . See more: https://www.lexpharma.com/media-center/news/786-lexicon-welcomes-new-esc-heart-failure-treatment-guidelines-establishing-sglt-inhibitors-as-standard-of-care

Videos (show all)

Telephone

Address


2445 Technology Forest Blvd, 11th Floor
The Woodlands, TX
77381

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Other Biotechnology in The Woodlands (show all)
Othram Inc. Othram Inc.
8301 New Trails Dr Ste 110
The Woodlands, 77381

Help us solve "unsolvable" cold cases and get closure for families.

VGXI INC VGXI INC
2700 Research Forest Dr, Ste 180
The Woodlands, 77381

VGXI, Inc. is a leading contract manufacturer of cGMP plasmid pharmaceuticals for DNA vaccine and gene therapy clinical trials and research.

Meridian Biotech Meridian Biotech
The Woodlands, 77380